speb/financial-data huggingface dataset:
INFU income_statement (quarterly, 2025-03-31) — Net Income: -267000.00
INFU income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -267000.00
INFU income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -267000.00
INFU income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -267000.00
INFU income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -267000.00
INFU cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -267000.00
INFU income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -267000.00
INFU income_statement (quarterly, 2025-03-31) — Net Interest Income: -336000.00
INFU cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 4824000.00
INFU cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 4824000.00
INFU income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -336000.00
INFU balance_sheet (quarterly, 2025-03-31) — Net PPE: 47781000.00
INFU cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2661000.00
INFU balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 45230000.00
INFU balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 6749000.00
INFU balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 6749000.00
INFU income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3909000.00
INFU income_statement (quarterly, 2025-03-31) — Normalized Income: -267000.00
INFU cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1780000.00
INFU cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -581000.00
INFU income_statement (quarterly, 2025-03-31) — Operating Income: 618000.00
INFU income_statement (quarterly, 2025-03-31) — Operating Revenue: 34716000.00
INFU balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 20973616.00
INFU balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3829000.00
INFU balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 7602000.00
INFU balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 870000.00
INFU income_statement (quarterly, 2025-03-31) — Other Gand A: 15316000.00
INFU income_statement (quarterly, 2025-03-31) — Other Income Expense: -29000.00
INFU balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 6208000.00
INFU cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 19000.00
INFU balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 3360000.00
INFU income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -29000.00
INFU balance_sheet (quarterly, 2025-03-31) — Other Properties: 110996000.00
INFU balance_sheet (quarterly, 2025-03-31) — Payables: 8367000.00
INFU balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 8367000.00
INFU balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
INFU income_statement (quarterly, 2025-03-31) — Pretax Income: 253000.00
INFU cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 159000.00
INFU balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
INFU cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 45000.00
INFU cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3415000.00
INFU balance_sheet (quarterly, 2025-03-31) — Receivables: 23892000.00
INFU income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 12477000.00
INFU income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3320000.00
INFU cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -14407000.00
INFU cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -3123000.00
INFU balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -60622000.00
INFU cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 754000.00
INFU income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2985000.00
INFU income_statement (quarterly, 2025-03-31) — Selling General And Administration: 18301000.00
INFU balance_sheet (quarterly, 2025-03-31) — Share Issued: 20973616.00
INFU cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1108000.00
INFU balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 55148000.00
INFU balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 45230000.00
INFU income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INFU income_statement (quarterly, 2025-03-31) — Tax Provision: 520000.00
INFU income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
INFU balance_sheet (quarterly, 2025-03-31) — Total Assets: 104282000.00
INFU balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 83855000.00
INFU balance_sheet (quarterly, 2025-03-31) — Total Debt: 33165000.00
INFU balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 55148000.00
INFU income_statement (quarterly, 2025-03-31) — Total Expenses: 34098000.00
INFU balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 49134000.00
INFU balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 68960000.00
INFU balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 33165000.00
INFU income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 618000.00
INFU balance_sheet (quarterly, 2025-03-31) — Working Capital: 19353000.00
INFU income_statement (quarterly, 2025-06-30) — +Operating Expense: 16097000.00
INFU income_statement (quarterly, 2025-06-30) — +Total Revenue: 36002000.00
INFU balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 9318000.00
INFU balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 24481000.00
INFU balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -76457000.00
INFU balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 115338000.00
INFU income_statement (quarterly, 2025-06-30) — Amortization: 247000.00
INFU cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 247000.00
INFU cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 247000.00
INFU income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 247000.00
INFU income_statement (quarterly, 2025-06-30) — Basic Average Shares: 20806967.00
INFU income_statement (quarterly, 2025-06-30) — Basic EPS: 0.12
INFU cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1506000.00
INFU cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1247000.00
INFU balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4107000.00
INFU balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
INFU balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 720000.00
INFU balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 720000.00
INFU cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -6110000.00
INFU cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1685000.00
INFU cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 7009000.00
INFU cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -398000.00
INFU cash_flow (quarterly, 2025-06-30) — Change In Inventory: 430000.00
INFU cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 275000.00
INFU cash_flow (quarterly, 2025-06-30) — Change In Payable: -398000.00
INFU cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -398000.00
INFU cash_flow (quarterly, 2025-06-30) — Change In Receivables: 6000.00
INFU cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 313000.00
INFU cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 6000.00
INFU cash_flow (quarterly, 2025-06-30) — Changes In Cash: -786000.00
INFU balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
INFU balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 54534000.00
INFU cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -3730000.00
INFU income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 16128000.00
INFU balance_sheet (quarterly, 2025-06-30) — Current Assets: 34800000.00
INFU balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 15861000.00
INFU cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 843000.00
INFU cash_flow (quarterly, 2025-06-30) — Deferred Tax: 843000.00
INFU cash_flow (quarterly, 2025-06-30) — Depreciation: 3094000.00
INFU cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3341000.00
INFU income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 247000.00
INFU cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 3341000.00
INFU income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 247000.00
INFU income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 21056460.00
INFU income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.12
INFU income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2599000.00
INFU income_statement (quarterly, 2025-06-30) — EBIT: 3819000.00
INFU income_statement (quarterly, 2025-06-30) — EBITDA: 7160000.00
INFU cash_flow (quarterly, 2025-06-30) — End Cash Position: 720000.00
INFU balance_sheet (quarterly, 2025-06-30) — Financial Assets: 949000.00
INFU cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -6110000.00
INFU cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 5762000.00
INFU cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -762000.00
INFU balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 717000.00
INFU income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 13146000.00
INFU balance_sheet (quarterly, 2025-06-30) — Goodwill: 3710000.00
INFU balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 10860000.00
INFU balance_sheet (quarterly, 2025-06-30) — Gross PPE: 121995000.00
INFU income_statement (quarterly, 2025-06-30) — Gross Profit: 19874000.00
INFU income_statement (quarterly, 2025-06-30) — Interest Expense: 373000.00
INFU income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 373000.00
INFU balance_sheet (quarterly, 2025-06-30) — Inventory: 5668000.00
INFU balance_sheet (quarterly, 2025-06-30) — Invested Capital: 80881000.00
INFU cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1685000.00
INFU cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 13486000.00
INFU balance_sheet (quarterly, 2025-06-30) — Leases: 5088000.00
INFU balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 4107000.00
INFU balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 26347000.00
INFU balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 30454000.00
INFU cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 13486000.00
INFU cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -15854000.00
INFU balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 6450000.00
INFU cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -3730000.00
INFU balance_sheet (quarterly, 2025-06-30) — Net Debt: 25627000.00
INFU income_statement (quarterly, 2025-06-30) — Net Income: 2599000.00
INFU income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2599000.00
INFU income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2599000.00
INFU income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2599000.00
INFU income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2599000.00
INFU cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2599000.00
INFU income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2599000.00
INFU income_statement (quarterly, 2025-06-30) — Net Interest Income: -373000.00
INFU cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -2368000.00
INFU cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -2368000.00
INFU income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -373000.00
INFU balance_sheet (quarterly, 2025-06-30) — Net PPE: 45538000.00
INFU cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -273000.00
INFU balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 43674000.00
INFU balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 5956000.00
INFU balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 5956000.00
INFU income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 7160000.00
INFU income_statement (quarterly, 2025-06-30) — Normalized Income: 2599000.00
INFU cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 7009000.00
INFU cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -762000.00
INFU income_statement (quarterly, 2025-06-30) — Operating Income: 3777000.00
INFU income_statement (quarterly, 2025-06-30) — Operating Revenue: 36002000.00
INFU balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 20425964.00
INFU balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3931000.00
INFU balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 6543000.00
INFU balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 717000.00
INFU income_statement (quarterly, 2025-06-30) — Other Gand A: 13146000.00
INFU income_statement (quarterly, 2025-06-30) — Other Income Expense: 42000.00
INFU balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 7150000.00
INFU cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 20000.00
INFU balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2746000.00
INFU income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 42000.00
INFU balance_sheet (quarterly, 2025-06-30) — Other Properties: 110457000.00
INFU balance_sheet (quarterly, 2025-06-30) — Payables: 9318000.00
INFU balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 9318000.00
INFU balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
INFU income_statement (quarterly, 2025-06-30) — Pretax Income: 3446000.00
INFU cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
INFU balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
INFU cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -6000.00
INFU cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1247000.00
INFU balance_sheet (quarterly, 2025-06-30) — Receivables: 24481000.00
INFU income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 13034000.00
INFU income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3341000.00
INFU cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -15854000.00
INFU cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -3730000.00
INFU balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -61523000.00
INFU cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 974000.00
INFU income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2704000.00
INFU income_statement (quarterly, 2025-06-30) — Selling General And Administration: 15850000.00
INFU balance_sheet (quarterly, 2025-06-30) — Share Issued: 20425964.00
INFU cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 661000.00
INFU balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 54534000.00
INFU balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 43674000.00
INFU income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
INFU income_statement (quarterly, 2025-06-30) — Tax Provision: 847000.00
INFU income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
INFU balance_sheet (quarterly, 2025-06-30) — Total Assets: 100849000.00
INFU balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 80881000.00
INFU balance_sheet (quarterly, 2025-06-30) — Total Debt: 30454000.00
INFU balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 54534000.00
INFU income_statement (quarterly, 2025-06-30) — Total Expenses: 32225000.00
INFU balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 46315000.00
INFU balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 66049000.00
INFU balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 30454000.00
INFU income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 3777000.00
INFU balance_sheet (quarterly, 2025-06-30) — Working Capital: 18939000.00
INFU income_statement (quarterly, 2025-09-30) — +Operating Expense: 17009000.00
INFU income_statement (quarterly, 2025-09-30) — +Total Revenue: 36488000.00
INFU balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 10024000.00
INFU balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 24309000.00
INFU balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -78287000.00
INFU balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 116259000.00
INFU income_statement (quarterly, 2025-09-30) — Amortization: 214000.00
INFU cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 214000.00
INFU cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 214000.00
INFU income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 214000.00
INFU income_statement (quarterly, 2025-09-30) — Basic Average Shares: 20413636.00
INFU income_statement (quarterly, 2025-09-30) — Basic EPS: 0.11
INFU cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 720000.00
INFU cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1106000.00
INFU balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3760000.00
INFU balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
INFU balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 955000.00
INFU balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 955000.00
INFU cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -8006000.00
INFU cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -252000.00
INFU cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 8493000.00
INFU cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1842000.00
INFU cash_flow (quarterly, 2025-09-30) — Change In Inventory: 78000.00
INFU cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -864000.00
INFU cash_flow (quarterly, 2025-09-30) — Change In Payable: 1842000.00
INFU cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1842000.00
INFU cash_flow (quarterly, 2025-09-30) — Change In Receivables: -78000.00
INFU cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 978000.00
INFU cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -78000.00
INFU cash_flow (quarterly, 2025-09-30) — Changes In Cash: 235000.00
INFU balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
INFU balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 55471000.00
INFU cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -2746000.00
INFU income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 15668000.00
INFU balance_sheet (quarterly, 2025-09-30) — Current Assets: 35571000.00
INFU balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 18718000.00
INFU cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 1167000.00
INFU cash_flow (quarterly, 2025-09-30) — Deferred Tax: 1167000.00
INFU cash_flow (quarterly, 2025-09-30) — Depreciation: 3070000.00
INFU cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3284000.00
INFU income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 214000.00
INFU cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3284000.00
INFU income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 214000.00
INFU income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 20946607.00
INFU income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.11
INFU income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2259000.00
INFU income_statement (quarterly, 2025-09-30) — EBIT: 3757000.00
INFU income_statement (quarterly, 2025-09-30) — EBITDA: 7041000.00
INFU cash_flow (quarterly, 2025-09-30) — End Cash Position: 955000.00
INFU balance_sheet (quarterly, 2025-09-30) — Financial Assets: 850000.00
INFU cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -8006000.00
INFU cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 7387000.00
INFU cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -602000.00
INFU balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 642000.00
INFU income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 14429000.00
INFU balance_sheet (quarterly, 2025-09-30) — Goodwill: 3710000.00
INFU balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 10787000.00
INFU balance_sheet (quarterly, 2025-09-30) — Gross PPE: 121718000.00
INFU income_statement (quarterly, 2025-09-30) — Gross Profit: 20820000.00
INFU income_statement (quarterly, 2025-09-30) — Interest Expense: 330000.00
INFU income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 330000.00
INFU balance_sheet (quarterly, 2025-09-30) — Inventory: 5590000.00
INFU balance_sheet (quarterly, 2025-09-30) — Invested Capital: 76403000.00
INFU cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -252000.00
INFU cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 8785000.00
INFU balance_sheet (quarterly, 2025-09-30) — Leases: 5089000.00
INFU balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 3760000.00
INFU balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 20932000.00
INFU balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 24692000.00
INFU cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 8785000.00
INFU cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -14004000.00
INFU balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 6410000.00
INFU cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
INFU cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -2746000.00
INFU balance_sheet (quarterly, 2025-09-30) — Net Debt: 19977000.00
INFU income_statement (quarterly, 2025-09-30) — Net Income: 2259000.00
INFU income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2259000.00
INFU income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2259000.00
INFU income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2259000.00
INFU income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2259000.00
INFU cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2259000.00
INFU income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2259000.00
INFU income_statement (quarterly, 2025-09-30) — Net Interest Income: -330000.00
INFU cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -5219000.00
INFU cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -5219000.00
INFU income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -330000.00
INFU cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -218000.00
INFU balance_sheet (quarterly, 2025-09-30) — Net PPE: 43431000.00
INFU cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -252000.00
INFU balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 44684000.00
INFU balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 4812000.00
INFU balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 4812000.00
INFU income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 7041000.00
INFU income_statement (quarterly, 2025-09-30) — Normalized Income: 2259000.00
INFU cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 8493000.00
INFU cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -602000.00
INFU income_statement (quarterly, 2025-09-30) — Operating Income: 3811000.00
INFU income_statement (quarterly, 2025-09-30) — Operating Revenue: 36488000.00
INFU balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 20327352.00
INFU balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 4717000.00
INFU balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 8694000.00
INFU balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 642000.00
INFU income_statement (quarterly, 2025-09-30) — Other Gand A: 14429000.00
INFU income_statement (quarterly, 2025-09-30) — Other Income Expense: -54000.00
INFU balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 7077000.00
INFU cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 22000.00
INFU balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3430000.00
INFU income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -54000.00
INFU balance_sheet (quarterly, 2025-09-30) — Other Properties: 110219000.00
INFU balance_sheet (quarterly, 2025-09-30) — Payables: 10024000.00
INFU balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 10024000.00
INFU balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
INFU income_statement (quarterly, 2025-09-30) — Pretax Income: 3427000.00
INFU cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 177000.00
INFU balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
INFU cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 63000.00
INFU cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
INFU cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1106000.00
INFU balance_sheet (quarterly, 2025-09-30) — Receivables: 24309000.00
INFU income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 12598000.00
INFU income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3284000.00
INFU cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -14004000.00
INFU cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -2746000.00
INFU balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -61432000.00
INFU cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 854000.00
INFU income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2366000.00
INFU income_statement (quarterly, 2025-09-30) — Selling General And Administration: 16795000.00
INFU balance_sheet (quarterly, 2025-09-30) — Share Issued: 20327352.00
INFU cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1322000.00
INFU balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 55471000.00
INFU balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 44684000.00
INFU income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
INFU income_statement (quarterly, 2025-09-30) — Tax Provision: 1168000.00
INFU income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.34
INFU balance_sheet (quarterly, 2025-09-30) — Total Assets: 98881000.00
INFU balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 76403000.00
INFU balance_sheet (quarterly, 2025-09-30) — Total Debt: 24692000.00
INFU balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 55471000.00
INFU income_statement (quarterly, 2025-09-30) — Total Expenses: 32677000.00
INFU balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 43410000.00
INFU balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 63310000.00
INFU balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 24692000.00
INFU income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 3811000.00
INFU balance_sheet (quarterly, 2025-09-30) — Working Capital: 16853000.00
INFU income_statement (annual, 2025-12-31) — +Operating Expense: 68376000.00
INFU income_statement (quarterly, 2025-12-31) — +Operating Expense: 16721000.00
INFU income_statement (annual, 2025-12-31) — +Total Revenue: 143436000.00
INFU income_statement (quarterly, 2025-12-31) — +Total Revenue: 36230000.00
INFU balance_sheet (annual, 2025-12-31) — Accounts Payable: 10821000.00
INFU balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 10821000.00
INFU balance_sheet (annual, 2025-12-31) — Accounts Receivable: 22901000.00
INFU balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 22901000.00
INFU balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -80041000.00
INFU balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -80041000.00
INFU balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 117461000.00
INFU balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 117461000.00
INFU balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -300000.00
INFU balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -300000.00
INFU income_statement (annual, 2025-12-31) — Amortization: 920000.00
INFU income_statement (quarterly, 2025-12-31) — Amortization: 211000.00
INFU cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 920000.00
INFU cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 211000.00
INFU cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 920000.00
INFU cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 211000.00
INFU income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 920000.00
INFU income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 211000.00
INFU income_statement (annual, 2025-12-31) — Basic Average Shares: 20657877.00
INFU income_statement (quarterly, 2025-12-31) — Basic Average Shares: 20297663.00
INFU income_statement (annual, 2025-12-31) — Basic EPS: 0.32
INFU income_statement (quarterly, 2025-12-31) — Basic EPS: 0.10
INFU cash_flow (annual, 2025-12-31) — Beginning Cash Position: 527000.00
INFU cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 955000.00
INFU cash_flow (annual, 2025-12-31) — Capital Expenditure: -8686000.00
INFU cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2918000.00
INFU balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 3427000.00
INFU balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 3427000.00
INFU balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
INFU balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
INFU balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 3186000.00
INFU balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 3186000.00
INFU balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 3186000.00
INFU balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 3186000.00
INFU cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -14959000.00
INFU cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2703000.00
INFU cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -6790000.00
INFU cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2192000.00
INFU cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 24408000.00
INFU cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 7126000.00
INFU cash_flow (annual, 2025-12-31) — Change In Account Payable: -708000.00
INFU cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -575000.00
INFU cash_flow (annual, 2025-12-31) — Change In Inventory: 1140000.00
INFU cash_flow (quarterly, 2025-12-31) — Change In Inventory: 199000.00
INFU cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -789000.00
INFU cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -1055000.00
INFU cash_flow (annual, 2025-12-31) — Change In Payable: -708000.00
INFU cash_flow (quarterly, 2025-12-31) — Change In Payable: -575000.00
INFU cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -708000.00
INFU cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -575000.00
INFU cash_flow (annual, 2025-12-31) — Change In Receivables: 263000.00
INFU cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2430000.00
INFU cash_flow (annual, 2025-12-31) — Change In Working Capital: -94000.00
INFU cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 999000.00
INFU cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 263000.00
INFU cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 2430000.00
INFU cash_flow (annual, 2025-12-31) — Changes In Cash: 2659000.00
INFU cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2231000.00
INFU balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
INFU balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
INFU balance_sheet (annual, 2025-12-31) — Common Stock Equity: 57326000.00
INFU balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 57326000.00
INFU cash_flow (annual, 2025-12-31) — Common Stock Payments: -10974000.00
INFU cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -1375000.00
INFU income_statement (annual, 2025-12-31) — Cost Of Revenue: 63140000.00
INFU income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 15795000.00
INFU balance_sheet (annual, 2025-12-31) — Current Assets: 36336000.00
INFU balance_sheet (quarterly, 2025-12-31) — Current Assets: 36336000.00
INFU balance_sheet (annual, 2025-12-31) — Current Liabilities: 20182000.00
INFU balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 20182000.00
INFU cash_flow (annual, 2025-12-31) — Deferred Income Tax: 2726000.00
INFU cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 196000.00
INFU cash_flow (annual, 2025-12-31) — Deferred Tax: 2726000.00
INFU cash_flow (quarterly, 2025-12-31) — Deferred Tax: 196000.00
INFU cash_flow (annual, 2025-12-31) — Depreciation: 12374000.00
INFU cash_flow (quarterly, 2025-12-31) — Depreciation: 3138000.00
INFU cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 13294000.00
INFU cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3349000.00
INFU income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 920000.00
INFU income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 211000.00
INFU cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 13294000.00
INFU cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3349000.00
INFU income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 920000.00
INFU income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 211000.00
INFU income_statement (annual, 2025-12-31) — Diluted Average Shares: 21097323.00
INFU income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 21065938.00
INFU income_statement (annual, 2025-12-31) — Diluted EPS: 0.31
INFU income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.10
INFU income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 6627000.00
INFU income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2036000.00
INFU income_statement (annual, 2025-12-31) — EBIT: 11922000.00
INFU income_statement (quarterly, 2025-12-31) — EBIT: 3757000.00
INFU income_statement (annual, 2025-12-31) — EBITDA: 25216000.00
INFU income_statement (quarterly, 2025-12-31) — EBITDA: 7106000.00
INFU cash_flow (annual, 2025-12-31) — End Cash Position: 3186000.00
INFU cash_flow (quarterly, 2025-12-31) — End Cash Position: 3186000.00
INFU balance_sheet (annual, 2025-12-31) — Financial Assets: 748000.00
INFU balance_sheet (quarterly, 2025-12-31) — Financial Assets: 748000.00
INFU cash_flow (annual, 2025-12-31) — Financing Cash Flow: -14959000.00
INFU cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2703000.00
INFU cash_flow (annual, 2025-12-31) — Free Cash Flow: 15722000.00
INFU cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 4208000.00
INFU cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -2789000.00
INFU cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -844000.00
INFU balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 565000.00
INFU balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 565000.00
INFU income_statement (annual, 2025-12-31) — General And Administrative Expense: 56969000.00
INFU income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 14078000.00
INFU balance_sheet (annual, 2025-12-31) — Goodwill: 3710000.00
INFU balance_sheet (quarterly, 2025-12-31) — Goodwill: 3710000.00
INFU balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 10576000.00
INFU balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 10576000.00
INFU balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 23201000.00
INFU balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 23201000.00
INFU balance_sheet (annual, 2025-12-31) — Gross PPE: 122034000.00
INFU balance_sheet (quarterly, 2025-12-31) — Gross PPE: 122034000.00
INFU income_statement (annual, 2025-12-31) — Gross Profit: 80296000.00
INFU income_statement (quarterly, 2025-12-31) — Gross Profit: 20435000.00
INFU cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 543000.00
INFU income_statement (annual, 2025-12-31) — Interest Expense: 1299000.00
INFU income_statement (quarterly, 2025-12-31) — Interest Expense: 260000.00
INFU income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1299000.00
INFU income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 260000.00
INFU cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1243000.00
INFU balance_sheet (annual, 2025-12-31) — Inventory: 5391000.00
INFU balance_sheet (quarterly, 2025-12-31) — Inventory: 5391000.00
INFU balance_sheet (annual, 2025-12-31) — Invested Capital: 76951000.00
INFU balance_sheet (quarterly, 2025-12-31) — Invested Capital: 76951000.00
INFU cash_flow (annual, 2025-12-31) — Investing Cash Flow: -6790000.00
INFU cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2192000.00
INFU cash_flow (annual, 2025-12-31) — Issuance Of Debt: 48226000.00
INFU cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 6724000.00
INFU balance_sheet (annual, 2025-12-31) — Leases: 5099000.00
INFU balance_sheet (quarterly, 2025-12-31) — Leases: 5099000.00
INFU balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3427000.00
INFU balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3427000.00
INFU balance_sheet (annual, 2025-12-31) — Long Term Debt: 19625000.00
INFU balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 19625000.00
INFU balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 23052000.00
INFU balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 23052000.00
INFU cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 48226000.00
INFU cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 6724000.00
INFU cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -52349000.00
INFU cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -8084000.00
INFU balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 6424000.00
INFU balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 6424000.00
INFU cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -1412000.00
INFU cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
INFU cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -10974000.00
INFU cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1375000.00
INFU balance_sheet (annual, 2025-12-31) — Net Debt: 16439000.00
INFU balance_sheet (quarterly, 2025-12-31) — Net Debt: 16439000.00
INFU income_statement (annual, 2025-12-31) — Net Income: 6627000.00
INFU income_statement (quarterly, 2025-12-31) — Net Income: 2036000.00
INFU income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 6627000.00
INFU income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2036000.00
INFU income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 6627000.00
INFU income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2036000.00
INFU income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6627000.00
INFU income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2036000.00
INFU income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6627000.00
INFU income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2036000.00
INFU cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 6627000.00
INFU cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2036000.00
INFU income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 6627000.00
INFU income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2036000.00
INFU income_statement (annual, 2025-12-31) — Net Interest Income: -1299000.00
INFU income_statement (quarterly, 2025-12-31) — Net Interest Income: -260000.00
INFU cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -4123000.00
INFU cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1360000.00
INFU cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -4123000.00
INFU cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -1360000.00
INFU income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1299000.00
INFU income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -260000.00
INFU cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -197000.00
INFU cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 33000.00
INFU balance_sheet (annual, 2025-12-31) — Net PPE: 41993000.00
INFU balance_sheet (quarterly, 2025-12-31) — Net PPE: 41993000.00
INFU cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -5378000.00
INFU cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -2192000.00
INFU balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 46750000.00
INFU balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 46750000.00
INFU balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 4640000.00
INFU balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 4640000.00
INFU balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 4640000.00
INFU balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 4640000.00
INFU income_statement (annual, 2025-12-31) — Normalized EBITDA: 25216000.00
INFU income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7106000.00
INFU income_statement (annual, 2025-12-31) — Normalized Income: 6627000.00
INFU income_statement (quarterly, 2025-12-31) — Normalized Income: 2036000.00
INFU cash_flow (annual, 2025-12-31) — Operating Cash Flow: 24408000.00
INFU cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 7126000.00
INFU cash_flow (annual, 2025-12-31) — Operating Gains Losses: -2789000.00
INFU cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -844000.00
INFU income_statement (annual, 2025-12-31) — Operating Income: 11920000.00
INFU income_statement (quarterly, 2025-12-31) — Operating Income: 3714000.00
INFU income_statement (annual, 2025-12-31) — Operating Revenue: 143436000.00
INFU income_statement (quarterly, 2025-12-31) — Operating Revenue: 36230000.00
INFU balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 20209636.00
INFU balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 20209636.00
INFU balance_sheet (annual, 2025-12-31) — Other Current Assets: 4858000.00
INFU balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4858000.00
INFU balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 9361000.00
INFU balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 9361000.00
INFU balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 565000.00
INFU balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 565000.00
INFU income_statement (annual, 2025-12-31) — Other Gand A: 56969000.00
INFU income_statement (quarterly, 2025-12-31) — Other Gand A: 14078000.00
INFU income_statement (annual, 2025-12-31) — Other Income Expense: 2000.00
INFU income_statement (quarterly, 2025-12-31) — Other Income Expense: 43000.00
INFU balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 6866000.00
INFU balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 6866000.00
INFU cash_flow (annual, 2025-12-31) — Other Non Cash Items: 81000.00
INFU cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 20000.00
INFU balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 6267000.00
INFU balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 6267000.00
INFU income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 2000.00
INFU income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 43000.00
INFU balance_sheet (annual, 2025-12-31) — Other Properties: 110511000.00
INFU balance_sheet (quarterly, 2025-12-31) — Other Properties: 110511000.00
INFU balance_sheet (annual, 2025-12-31) — Payables: 10821000.00
INFU balance_sheet (quarterly, 2025-12-31) — Payables: 10821000.00
INFU balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 10821000.00
INFU balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 10821000.00
INFU balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
INFU balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
INFU income_statement (annual, 2025-12-31) — Pretax Income: 10623000.00
INFU income_statement (quarterly, 2025-12-31) — Pretax Income: 3497000.00
INFU cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 335000.00
INFU cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -1000.00
INFU balance_sheet (annual, 2025-12-31) — Properties: 0.00
INFU balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
INFU cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 200000.00
INFU cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 98000.00
INFU cash_flow (annual, 2025-12-31) — Purchase Of Business: -1412000.00
INFU cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
INFU cash_flow (annual, 2025-12-31) — Purchase Of PPE: -8686000.00
INFU cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -2918000.00
INFU balance_sheet (annual, 2025-12-31) — Receivables: 22901000.00
INFU balance_sheet (quarterly, 2025-12-31) — Receivables: 22901000.00
INFU income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 50766000.00
INFU income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 12657000.00
INFU income_statement (annual, 2025-12-31) — Reconciled Depreciation: 13294000.00
INFU income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3349000.00
INFU cash_flow (annual, 2025-12-31) — Repayment Of Debt: -52349000.00
INFU cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -8084000.00
INFU cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -10974000.00
INFU cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1375000.00
INFU balance_sheet (annual, 2025-12-31) — Retained Earnings: -60702000.00
INFU balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -60702000.00
INFU cash_flow (annual, 2025-12-31) — Sale Of PPE: 3308000.00
INFU cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 726000.00
INFU income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 10487000.00
INFU income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2432000.00
INFU income_statement (annual, 2025-12-31) — Selling General And Administration: 67456000.00